SecBot SecBot
SC 13G ·Filed Nov 6, 2026

GOSS

Gossamer Bio, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed10d 15h ago SEC0000315066-26-002941
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any subsequent 13D conversion or additional accumulation by Fidelity. The 10.9% stake is significant for a micro-cap biotech and could signal conviction ahead of clinical catalysts.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$9.77
T+0 close · Nov 6, 2026 · via day close
Latest settled
+12.28%
T+5 · $10.97
Vs SPY
+9.69%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $9.77entry
  2. T+1 · 8d ago +8.96%α +6.59% · $10.65
  3. T+5 · 4d ago +12.28%α +9.69% · $10.97
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) disclosed a 10.9% passive stake in Gossamer Bio via Schedule 13G, with 667,465 shares held as of October 30, 2026. The stake is held through Fidelity Management & Research Company LLC, an investment adviser. This is a new filing by FMR; no prior 13G from this filer was found in the cross-filing context.

Key Financial Metrics

Stake
10.9%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reported beneficial ownership of 667,465 shares of Gossamer Bio common stock as of October 30, 2026
  • The stake represents 10.9% of shares outstanding
  • Fidelity Management & Research Company LLC is the investment adviser with 5%+ ownership
  • The filing certifies passive intent under Rule 13d-1(b)
  • Select Biotechnology Portfolio held 667,460 shares (10.9%) of the total
  • This is a new SC 13G filing by FMR LLC; no prior 13G from this filer was found in the cross-filing context

Financial Impact

10.9% stake valued at approximately $6.6 million based on $61M market cap

ownership concentration

Risk Factors

  • FMR's passive certification could change if it later engages with management or seeks board representation
  • Micro-cap biotech with high volatility; large holder could influence stock via entry/exit

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000315066-26-002941
Document: 0000315066-26-002941-index-headers.html0000315066-26-002941
Document: 0000315066-26-002941-index.html0000315066-26-002941
Document: 0000315066-26-002941.txt0000315066-26-002941

Track record

20 reports on GOSS

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.28% at T+60 after the Jun 17, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today S-3 Neutral 3/10 Entry $10.98 Now $10.98 −0.00% settles Feb 16
  2. Nov 10, 20266d ago 8-K Neutral 5/10 Entry $11.69 Now $10.98 −6.07% settles Feb 9
  3. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $10.65 Now $10.98 +3.15% settles Feb 5
  4. Nov 6, 202610d ago SC 13G Neutral 4/10 Viewing Entry $9.77 Now $10.98 +12.38% settles Feb 4
  5. Oct 29, 202618d ago SC 13D/A Bearish 5/10 Entry $10.38 Now $10.98 −5.78% settles Jan 28
  6. Oct 8, 20265w ago SC 13D/A Bearish 5/10 Entry $9.31 Now $10.98 −17.94% settles Jan 6
  7. Sep 28, 20267w ago SC 13D/A Bearish 6/10 Entry $11.58 Now $10.98 +5.18% settles Dec 23
  8. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $11.69 Now $10.98 −6.07% settles Dec 16
  9. Sep 16, 20268w ago 8-K Neutral 4/10 Entry $11.94 Now $10.98 −8.04% settles Dec 11
  10. Sep 11, 20269w ago 8-K Bearish 6/10 Entry $10.73 Now $10.98 −2.33% settles Dec 7
Showing 10 of 20

US Market Status

Market Closed · Opens in 8h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026